CUTTING EDGE SCIENCE
ABOUT
Hylomorph is a Medtech Startup company, spin-off of the Swiss Federal Institute of Technology.
We specialize in cutting-edge combination of micro-engineering and biotechnology into innovative biomaterials for healthcare products.
​
Hylomorph's core technology optimizes the interface between implantable medical devices and the biological tissues.
​
Our headquarter is based at Technopark Zurich, in the heart of Switzerland.
​
Curious to know more about what we do? Click below and listen to Hylomorph CEO, Dr. Simone Bottan.
TEAM
Credits: Lichtsteiner Foundation
Simone Bottan
CHIEF EXECUTIVE OFFICER
Francesco Robotti
CHIEF OPERATING OFFICER
Aldo Ferrari
CHIEF SCIENTIFIC OFFICER
Sonia Schmocker
CHIEF REGULATORY & QUALITY OFFICER
Georgios Stefopoulos
HEAD OF PRODUCT DEVELOPMENT
Sebastian Cavalli
QUALITY SPECIALIST
Cherry Malonzo
REGULATORY & QUALITY
WRITER
Eunice Nazario
REGULATORY & QUALITY ASSOCIATE
BOARD OF DIRECTORS
Giovanni Leo
BOARD CHAIRPERSON
Gian-Luigi Berini
BOARD MEMBER
Peter Gabriel
BOARD MEMBER
Simone Bottan
CHIEF EXECUTIVE OFFICER
Aldo Ferrari
CHIEF SCIENTIFIC OFFICER
AWARDS AND SUPPORT
Co-funded by the Horizon 2020 programme of the European Union